During the past decade, University Hospital Mainz conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 11 clinical trials were completed, i.e. on average, 19% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 8 clinical trials were completed. i.e. 29.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Mainz" #1 sponsor was "Johannes Gutenberg University Mainz" with 28 trials, followed by "Gilead Sciences" with 4 trials sponsored, "Johann Wolfgang Goethe University Hospital" with 4 trials sponsored, "Horizon Pharma USA, Inc." with 3 trials sponsored and "Universitätsklinikum Hamburg-Eppendorf" with 3 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Mainz" #1 collaborator was "Johannes Gutenberg University Mainz" with 4 trials as a collaborator, "Bayer" with 3 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials as a collaborator, "Boehringer Ingelheim" with 2 trials as a collaborator and "German Federal Ministry of Education and Research" with 2 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Mainz" are "Acute Myeloid Leukemia" (4 trials), "Heart Failure" (4 trials), "Hepatitis C, Chronic" (3 trials), "Myelodysplastic Syndrome" (3 trials) and "Acute Lymphoblastic Leukemia" (2 trials). Many other conditions were trialed in "University Hospital Mainz" in a lesser frequency.

Most popular intervention types in "University Hospital Mainz" are "Drug" (34 trials), "Other" (16 trials), "Device" (14 trials), "Procedure" (12 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "ATIR101" (2 trials), "Copegus®" (2 trials), "Fluconazole" (2 trials) and "Fulvestrant" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Mainz" are 93 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 34 active trials in "University Hospital Mainz". 2 are not yet recruiting, 19 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 41 completed trials in University Hospital Mainz, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Mainz, 6 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 18 trials that are defined as “Not Applicable".